Published: December 22, 2021
Data from Pfizer’s clinical trial showed two-drug antiviral regimen was 90% effective in preventing hospitalizations and deaths in high-risk patients
Pfizer Inc said on Wednesday the US Food and Drug Administration (FDA) authorized its antiviral Covid-19 pill, making it the first at-home treatment for the coronavirus that is expected to become an important tool in the fight against the fast spreading Omicron variant.
Data from Pfizer’s clinical trial showed its two-drug antiviral regimen was 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness. Recent lab data suggests the drug retains its effectiveness against Omicron.
Continue reading...from The Guardian https://ift.tt/3Je8fn5
via
0 Comments